NCT05098015

Brief Summary

The study is a randomized controlled trial (RCT) of Game Changers, an 8-session peer-led group intervention that aims to empower and mobilize people living with HIV (PLWH) to be agents for HIV prevention in their social networks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
809

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 28, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

January 24, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 15, 2026

Completed
Last Updated

January 15, 2026

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

October 18, 2021

Results QC Date

September 19, 2025

Last Update Submit

December 23, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • HIV Testing

    For each index participant (PLWH), data is examined from their enrolled alters and the percent of these alters who self-reported HIV testing behavior (yes/no) at each follow-up assessment is calculated, followed by the average percent across all follow-up assessments. Therefore, data from all three follow-up timepoints (months 6, 12 18) were pooled and an average calculated across the timepoints.

    Data regarding HIV testing over the past 6 months, assessed at each follow-up assessment (Months 6, 12, 18)

  • Condom Use

    For each index participant (PLWH), data is examined from their enrolled alters and the percent of these alters who self-reported always using condoms use during intercourse at each follow-up assessment is calculated, followed by the average percentage across all follow-up assessments. Therefore, data from all three follow-up timepoints (months 6, 12 18) were pooled and an average calculated across the timepoints.

    Reports of always using condoms in the past 6 months, as assessed at each follow-up assessment (Month 6, Month 12, Month 18)

Secondary Outcomes (2)

  • Internalized HIV Stigma

    Reported at each follow-up assessment (Months 6, 12, 18)

  • HIV Prevention Advocacy

    Past 6 months as assessed at each follow-up (Months 6, 12, 18)

Study Arms (4)

Intervention- index

EXPERIMENTAL

8-session group intervention to train index participants to engage in HIV prevention advocacy.

Behavioral: Game Changers

Usual care control- index

NO INTERVENTION

Participants will receive HIV usual care, and no added intervention.

Intervention- alter

NO INTERVENTION

Enrolled alter participants recruited by index participants assigned to the intervention comprise this arm

Usual care control- alter

NO INTERVENTION

ALter participants recruited by index participants assigned to the usual care control group comprise this arm

Interventions

Game ChangersBEHAVIORAL

8-session group intervention that uses didactic instruction, role plays and experience sharing to empower participants to engage in HIV prevention advocacy.

Intervention- index

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 years and older
  • HIV-positive
  • in HIV care at The Infectious DIseases Institute for at least one year

You may not qualify if:

  • Participated in the prior pilot study of the intervention.
  • Has significant cognitive impairment
  • Health status is not sufficiently stable to reliably complete 18 month study.
  • Does not speak Luganda fluently (index participant); English or Luganda fluently (social network participant)
  • spouse/partner or household member are enrolled as index participant in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Infectious Diseases Institute

Kampala, Uganda

Location

Related Publications (2)

  • Bogart LM, Matovu JKB, Green HD Jr, Ninsiima S, Klein DJ, Gwokyalya V, Serunkuuma R, Ghosh-Dastidar B, Mubiru K, Nabukeera M, Malika N, Okoboi S, Wagner GJ. Randomized Controlled Trial of Game Changers, a Social Network Intervention for HIV Prevention in Uganda. AIDS Behav. 2025 Nov 11:10.1007/s10461-025-04907-4. doi: 10.1007/s10461-025-04907-4. Online ahead of print.

  • Wagner GJ, Bogart LM, Green HD, Storholm ED, Klein DJ, McBain RK, Serunkuuma R, Mubiru K, Matovu JKB, Okoboi S. Social network-based group intervention to promote HIV prevention in Uganda: study protocol for a cluster randomized controlled trial of Game Changers. Trials. 2022 Mar 28;23(1):233. doi: 10.1186/s13063-022-06186-z.

Results Point of Contact

Title
Glenn Wagner
Organization
RAND

Study Officials

  • Glenn Wagner

    RAND

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessment interviewer will be blinded to study arm allocation of the participants at baseline only.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Individual randomization of index participants (and their recruited alter participants) to one of two parallel groups, the intervention or usual care (no intervention) control group. Therefore there are 4 study groups: index intervention, alter intervention, index control and alter control
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 28, 2021

Study Start

January 24, 2022

Primary Completion

October 25, 2024

Study Completion

October 25, 2024

Last Updated

January 15, 2026

Results First Posted

January 15, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

A de-identified dataset will be made available upon review of requests from outside researchers

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Following publication of primary results of the study (approximately August 2026).

Locations